Rubius Therapeutics

-$0.11 (-0.73%) As of 1:45 PM UTC today

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell RUBY and other ETFs, options, and stocks.

About RUBY

Rubius Therapeutics, Inc. engages in the development of red-cell therapeutic medicines for cancer, autoimmune diseases, hemophilia, and infectious and metabolic diseases. The company was founded by Avak Kahvejian, Jordi Mata-Fink, and Noubar Afeyan on April 26, 2013 and is headquartered in Cambridge, MA.

CEO
Pablo J. Cagnoni
Employees
204
Headquarters
Cambridge, Massachusetts
Founded
2013

RUBY Key Statistics

Market Cap
1.28B
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
236.38K
High Today
$14.50
Low Today
$14.25
Open Price
$14.43
Volume
6.06K
52 Week High
$38.71
52 Week Low
$4.20

RUBY News

Simply Wall St44m

Are Rubius Therapeutics, Inc. Investors Paying Above The Intrinsic Value?

Today we will run through one way of estimating the intrinsic value of Rubius Therapeutics, Inc. ( ) by taking the expected future cash flows and discounting th

RUBY Earnings

-$0.60
-$0.40
-$0.20
$0.00
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Estimated
— per share
Actual
Expected Nov 8, Pre-Market
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure